Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) | RFA HL 19 002

Opportunity Information: Apply for RFA HL 19 002

Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) research education grant opportunity led by the National Heart, Lung, and Blood Institute (NHLBI). It uses the NIH Research Education Program mechanism (R25), which is designed to support structured educational and mentoring activities that strengthen the biomedical research workforce. The central purpose of this specific PRIDE funding opportunity is to expand and sustain diversity in health-related research by improving the research training and career development of junior faculty from backgrounds that are underrepresented in the biomedical sciences, particularly in fields aligned with NHLBI priorities.

A defining feature of the program is its emphasis on long-term mentoring with the explicit goal of helping participants build independent research careers and become competitive for NIH funding. Rather than supporting standalone workshops or short-term training only, the program is intended to create durable mentoring relationships and a supportive career development environment that helps junior faculty develop a research program, refine their scientific direction, and strengthen the skills needed to submit successful grant applications. The opportunity specifically calls for applications from senior faculty, established researchers, and experienced mentors who can design and direct Summer Institutes (SIs) under the PRIDE program and provide high-quality mentorship to promising candidates.

In terms of content and structure, the FOA prioritizes creative, well-organized educational activities centered on three main components: research experiences, mentoring activities, and courses for skills development. These activities are expected to focus on heart, lung, blood, and sleep (HLBS) disorders research, as well as cross-cutting methodological approaches that apply across these scientific areas. In practice, this means proposed programs should not only expose participants to HLBS-related research questions, but also build practical capabilities that translate into research productivity and funding readiness, such as research design and analysis skills, responsible conduct, grantsmanship, and other competencies that strengthen independence and competitiveness in academic research.

Eligibility is geared toward U.S.-based institutions and organizations capable of running a robust research education and mentoring program. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and other eligible organizations as permitted by NIH policy in the announcement. The FOA also highlights eligibility for several institution types that commonly serve underrepresented communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, the opportunity makes clear that foreign institutions are not eligible to apply, and foreign components are not allowed, including non-U.S. components of U.S. organizations, consistent with NIH policy definitions.

Administratively, this opportunity is a discretionary grant competition under the NIH umbrella. The funding opportunity number is RFA-HL-19-002, and it is associated with CFDA numbers 93.233, 93.837, 93.838, 93.839, and 93.840, reflecting alignment with multiple NIH/NHLBI assistance listings. The original closing date listed for applications was April 6, 2018, and the posting indicates that clinical trials are not allowed under this R25 announcement, meaning applicants should propose education and mentoring activities rather than clinical trial conduct. Overall, the grant is aimed at building scalable, mentor-driven training environments that measurably strengthen the research trajectory of underrepresented junior faculty in HLBS-related science and improve the diversity and capacity of the national biomedical research workforce.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.837, 93.838, 93.839, 93.840.
• This funding opportunity was created on 2018-01-30.
• Applicants must submit their applications by 2018-04-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.

Apply for RFA HL 19 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: